Acutaas Chemicals Q3 FY26 PAT more than doubles YoY on strong revenue growth

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionResults View source PDF Explain this filing

ACUTAAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹1923.00

prior close

₹1930.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.9%-1.6% vs market

Pharmaceuticals peers, median of 157sector+1.0%-1.7% vs sector

On the reaction day the stock moved 1.6 pts less than Nifty Smallcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+0.3

15m

+0.9

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7+0.9-1.6+1.0-1.7

Next day

+1.4-0.8+2.2+0.4+1.1

+1.9+2.1-0.2+2.4-0.5

+3.0+2.9+0.1+2.9+0.2

+2.9+1.8+1.0+2.2+0.7

+2.7+1.5+1.2+2.1+0.6

+6.3+4.6+1.7+4.3+2.0

15d

+9.5+2.1+7.4+1.2+8.3

+14.4-0.3+14.7-0.6+15.0

+33.4-8.6+42.0-10.4+43.8

+34.8+7.0+27.8+3.2+31.6

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Acutaas Chemicals posted strong Q3 FY26 results. Standalone revenue rose about 42% YoY to around Rs 391 crore with PAT up to about Rs 112 crore from Rs 45 crore. Consolidated revenue was about Rs 396 crore and PAT about Rs 106 crore. Nine months standalone revenue grew 32% to about Rs 902 crore; PAT more than doubled to Rs 225 crore. Margins expanded meaningfully. Auditor Maheshwari and Co gave a clean limited review.

Likely market impact

Sharp revenue and PAT growth with margin expansion and clean audit is positive for stock sentiment.